2001
Initial Plasma HIV-1 RNA Levels and Progression to AIDS in Women and Men
Sterling T, Vlahov D, Astemborski J, Hoover D, Margolick J, Quinn T. Initial Plasma HIV-1 RNA Levels and Progression to AIDS in Women and Men. New England Journal Of Medicine 2001, 344: 720-725. PMID: 11236775, DOI: 10.1056/nejm200103083441003.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultAnti-HIV AgentsCD4 Lymphocyte CountDisease ProgressionDisease-Free SurvivalEligibility DeterminationFemaleHIV AntibodiesHIV InfectionsHIV-1HumansLongitudinal StudiesMalePractice Guidelines as TopicRegression AnalysisReverse Transcriptase Polymerase Chain ReactionRiskRNA, ViralSex FactorsViral LoadConceptsInitial viral loadMedian initial viral loadHIV-1 RNAViral loadLymphocyte countHuman immunodeficiency virus type 1 (HIV-1) infectionPlasma HIV-1 RNA levelsHIV-1 RNA levelsHIV-1 RNA copiesFemale injection drug usersVirus type 1 infectionHIV-1 seroconversionMedian initial CD4Risk of progressionHIV-1 infectionType 1 infectionInjection drug usersLikelihood of progressionRate of progressionAntiretroviral therapyInitial CD4Hazard ratioAntiretroviral treatmentTreatment guidelinesImmunodeficiency syndrome
1995
Medical Eligibility, Comprehension of the Consent Process, and Retention of Injection Drug Users Recruited for an HIV Vaccine Trial
Harrison K, Vlahov D, Jones K, Charron K, Clements M. Medical Eligibility, Comprehension of the Consent Process, and Retention of Injection Drug Users Recruited for an HIV Vaccine Trial. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 10: 386-390. PMID: 7552502, DOI: 10.1097/00042560-199511000-00012.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAIDS VaccinesClinical Trials as TopicComprehensionConsent FormsDouble-Blind MethodEducational StatusEligibility DeterminationFemaleHIV InfectionsHumansInformed ConsentMaleMiddle AgedPatient SelectionResearch DesignResearch SubjectsSubstance Abuse, IntravenousSurveys and QuestionnairesConceptsInjection drug usersHIV vaccine trialsVaccine trialsDrug usersHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionPhase II trialInformed consent procedureConsent proceduresII trialVirus infectionHigh riskMedical reasonsMedical eligibilityTrialsConsent processEnrollmentFollowInfectionFalse testVisits